Ochsner Blood Cancer Program
Hematology
Dr. Robert V. Emmons, MD
|
|
Give Review
Robert Emmons practices Hematology. He attended University of Cincinnati College of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Dr. Robert V. Emmons is a published physician. He published 22 publications, including: 'Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve mark...' Dr. Robert V. Emmons accepts Medicare payments and is listed with Medicare.gov.
Publications
- Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival.
- Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors.
- Gene transfer into hematopoietic progenitor and stem cells: progress and problems.
- Readers' responses to "Cancer of unknown primary site: advances in diagnostics".
- Expression of interferon-gamma by stromal cells inhibits murine long-term repopulating hematopoietic stem cell activity.
- Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve mark...
- Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.
- Changes in immunological parameters during interleukin 2 and interferon 2 alpha treatment of recurrent renal cell carcinoma and malignant melanoma.
- The administration of 10 microg/kg granulocyte colony-stimulating factor (G-CSF) alone results in a successful peripheral blood stem cell collection when previous mobi...
- Stem cell engraftment strategies.
- Successful autologous bone marrow transplant without the use of blood product support.
- Lymphohematopoietic stem cell engraftment.
- Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients.
- Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation.
- Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support.
- High-dose cyclophosphamide, BCNU, and VP-16 (CBV) conditioning before allogeneic stem cell transplantation for patients with non-Hodgkin''s lymphoma.
- Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
- Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism.
- Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy.
- Foxp3-expressing T regulatory cells and mast cells in acute graft-versus-host disease of the skin.
- Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with pro...
Schools
University Of Cincinnati College Of Medicine
University Of Michigan Medical Center
National Institutes Of Health
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
National Institutes of Health Clinical Center -
University of Michigan Hospitals and Health Centers -
University of Cincinnati College of Medicine
Hospital
-
Ochsner Medical Center
Drug Facts
| NPI NUMBER | 1407844574 | |
| NPPES Provider LastName | EMMONS | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 701212429 | |
| NPPES Provider State | LA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 230.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1407844574 |
| Last Name Of The Provider | EMMONS |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
Dr. Marc J. Kahn, MD |
|
Dr. Charles V. Wendling Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Suma P. Satti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meredith A. Lakey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas M. Reske, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suzette L. Cullins, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christos G. Theodossiou, MD |
|
Dr. M'Liss A. Hudson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Perry G. Rigby, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard C. Kline, MD
This Doctor is OpenDoctor Recommended.
|